Your browser doesn't support javascript.
loading
Recurrent toxocariasis due to chronic urticaria and successful treatment with prolonged albendazole therapy.
Karagöz, Ergenekon; Selek, Mehmet Burak; Aydin, Ersin; Hatipoglu, Mustafa; Turhan, Vedat; Acar, Ali; Öncül, Oral; Görenek, Levent.
Affiliation
  • Karagöz E; Department of Infectious, Diseases and Microbiology, GATA Haydarpasa Training Hospital, Istanbul, Turkey. ergenekonkaragoz@hotmail.com.
Turkiye Parazitol Derg ; 39(1): 83-5, 2015 Mar.
Article in En | MEDLINE | ID: mdl-25917592
ABSTRACT
Toxocariasis is a worldwide human helminthiasis, especially seen in temperate and tropical climate regions around the world. The diagnosis of this disease is performed on the basis of clinical symptoms and laboratory findings. Albendazole is one of the treatment choices for toxocariasis, with a currently recommended regimen of 10 mg/kg/day in two doses (400 mg twice daily) for 5 days. However, there is no precise consensus about the duration of the treatment. In this article, we report a case of toxocariasis; the patient visited our infectious disease polyclinic with complaints of long-term itching and urticarial skin lesions that were resistant to routine treatment and that recurred. Then, recurrent disease was resolved and skin lesions were diminished after prolonged albendazole therapy.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Toxocariasis / Albendazole / Anthelmintics Type of study: Diagnostic_studies Limits: Animals / Humans / Male Language: En Journal: Turkiye Parazitol Derg Year: 2015 Document type: Article Affiliation country: Turkey

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Toxocariasis / Albendazole / Anthelmintics Type of study: Diagnostic_studies Limits: Animals / Humans / Male Language: En Journal: Turkiye Parazitol Derg Year: 2015 Document type: Article Affiliation country: Turkey